DATABASE
Home
Database
Who We Are
What We Offer
Register
Sign In
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name
Category
CYIOS CORP Files SEC form 10-Q, Quarterly Report
News
CYIOS CORP Files SEC form 10-Q/A, Quarterly Report
News
CYIOS CORP Financials
News
CYIOS Corp.
Fund
CYMAT Advised of TSX Listing Review
News
Cymat Reports Fiscal 2013 Third Quarter Results
News
CYMAT Signs Debt Settlement Agreement with Industry Canada
News
Cymat Tech
Fund
CYMER INC Files SEC form 10-Q, Quarterly Report
News
CYMER INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to S
News
CYMER INC Financials
News
Cymer Inc.
Fund
Cymer Reaches New 52-Week High (CYMI)
News
Cymer Rises On Unusually High Volume (CYMI)
News
Cymer Stock Hits New 52-Week High (CYMI)
News
Cymer, Inc.
Company
Cynapsus Announces Completion of Short Form Prospectus Offering
News
Cynapsus Announces Continuation Of Short Form Prospectus Offering
News
Cynapsus Grants Stock Options
News
Cynapsus Raises Additional $1.3 Million As Part Of Short Form Prospectus Offering
News
Cynapsus Therapeutics Appoints Two New Directors
News
Cynapsus Therapeutics Grants Stock Options
News
Cynapsus Therapeutics Inc.
Fund
Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Disease and Its Alternative D
News
Cynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Disease and Its Alternative Delivery Development Candidate
News
Page 1059 of 1069